AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23925396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 21282767 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 255
Study 21282767 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 255
Study 21282767 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 255
Study 19309415 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (CLO), 0.1 mg or 0.15 mg b.i.d., for 6 days
Number of subjects: 160
Study 17372257 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in fasting insulin by 1 microunit/mL
Number of subjects: 57
Study 17372257 — intervention group
Group type: COMPARATOR
Intervention: Participants with >39% body fat and >4.5 microunits/mL insulin levels
Number of subjects: 57
Study 17372257 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% loss of body fat over time
Number of subjects: 57
Study 17372257 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in body fat percentage or insulin over time
Number of subjects: 57
Study 13129740 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan therapy for 8 weeks
Number of subjects: 64
Study 12167879 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheddar cheese
Number of subjects: 0
Study 12167879 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk
Number of subjects: 0
Study 12167879 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% milk
Number of subjects: 0
Study 12167879 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk
Number of subjects: 0
Study 12167879 — intervention group
Group type: EXPERIMENTAL
Intervention: Chocolate milk
Number of subjects: 0
Study 12167879 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 0
Study 12167879 — intervention group
Group type: COMPARATOR
Intervention: Apple juice
Number of subjects: 0
Study 12167879 — intervention group
Group type: COMPARATOR
Intervention: Cola beverage
Number of subjects: 0
Study 12167879 — intervention group
Group type: COMPARATOR
Intervention: Sweetened (strawberry) yogurt
Number of subjects: 0
Study 12167879 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy products (except sweetened yogurt)
Number of subjects: 0
Study 9185432 — intervention group
Group type: COMPARATOR
Intervention: PCA (Patient-Controlled Analgesia)
Number of subjects: 36
Study 9185432 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA+BI (Patient-Controlled Analgesia with nighttime morphine infusion)
Number of subjects: 36
Study 8267401 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and postoperative chemotherapy (treatment A) [5-drug combination chemotherapy + tamoxifen]
Number of subjects: 209
Study 8267401 — intervention group
Group type: COMPARATOR
Intervention: Pre- and postoperative radiotherapy (treatment B)
Number of subjects: 209
Study 8267401 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders to chemotherapy (treatment A)
Number of subjects: 209
Study 8267401 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-responders to chemotherapy (treatment A)
Number of subjects: 209
Study 3790404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release theophylline (SRT) administered under fasting conditions
Number of subjects: 16
Study 3790404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release theophylline (SRT) administered after a standardised breakfast
Number of subjects: 16
Study 3790404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release theophylline (SRT) administered under fasting conditions in the evening (adults only)
Number of subjects: 16
Study 3790404 — intervention group
Group type: COMPARATOR
Intervention: Intravenous theophylline as a reference
Number of subjects: 16
Study 3790404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release theophylline (SRT) in children with food
Number of subjects: 16
Study 29525770 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined classroom curriculum and parental intervention (STAMPP)
Number of subjects: 10233
Study 29525770 — intervention group
Group type: COMPARATOR
Intervention: Alcohol education as normal (EAN)
Number of subjects: 10233
Study 26676203 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implants placed in fresh sockets associated with chronic periapical disease (test group)
Number of subjects: 60
Study 26676203 — intervention group
Group type: COMPARATOR
Intervention: Healthy fresh sockets (control group)
Number of subjects: 60
Study 24512981 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabectedin 1.5mg/m2 24‐h intravenous infusion every 3 weeks (Arm A)
Number of subjects: 121
Study 24512981 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin 75 mg/m2 i.v., q3wk or doxorubicin 60 mg/m2 plus ifosfamide (6‐9 g/m2) i.v. q3wk (Arm B)
Number of subjects: 121
Study 23265034 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25%
Number of subjects: 30
Study 23265034 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.25%
Number of subjects: 30
Study 20656163 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral epinephrine (0.2 mL, 1:5000 solution)
Number of subjects: 149
Study 20656163 — intervention group
Group type: COMPARATOR
Intervention: Control group (no epinephrine)
Number of subjects: 149
Study 18635256 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate plus etanercept 50 mg/week
Number of subjects: 542
Study 18635256 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate alone (titrated from 7.5 mg to 20 mg/week)
Number of subjects: 542
Study 15766304 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (500 to 1000 mg titrated to 2000 mg/day, maximum 3000 mg/day)
Number of subjects: 34
Study 12186343 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial preparation (IP) including scaling and root planing followed by apically repositioned flap surgery
Number of subjects: 18
Study 12186343 — intervention group
Group type: COMPARATOR
Intervention: Initial preparation (IP) only
Number of subjects: 18
Study 10568044 — intervention group
Group type: EXPERIMENTAL
Intervention: Tardyferon (1 tablet per day for two months starting on the 4th day after delivery)
Number of subjects: 60
Study 10568044 — intervention group
Group type: EXPERIMENTAL
Intervention: Tardyferon Fol (1 tablet per day for two months starting on the 4th day after delivery)
Number of subjects: 60
Study 10568044 — intervention group
Group type: COMPARATOR
Intervention: No medication (Control group)
Number of subjects: 60
Study 8923571 — intervention group
Group type: EXPERIMENTAL
Intervention: brofaromine or fluvoxamine
Number of subjects: 44
Study 2009366 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg per day cyclosporine A (CyA) from day -1 to day +20 after bone marrow transplant (BMT)
Number of subjects: 81
Study 2009366 — intervention group
Group type: COMPARATOR
Intervention: 5 mg/kg per day cyclosporine A (CyA) from day -1 to day +20 after bone marrow transplant (BMT)
Number of subjects: 81
Study 2009366 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg per day cyclosporine A (CyA)
Number of subjects: 81
Study 2009366 — intervention group
Group type: COMPARATOR
Intervention: 5 mg/kg per day cyclosporine A (CyA)
Number of subjects: 81
Study 7171417 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment with tubocurarine
Number of subjects: 0
Study 7171417 — intervention group
Group type: COMPARATOR
Intervention: Suxamethonium administration
Number of subjects: 0
Study 31348298 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular electroacupuncture combined with body acupuncture
Number of subjects: 80
Study 31348298 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80
Study 30477832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tualang Honey (20g/day)
Number of subjects: 100
Study 30477832 — intervention group
Group type: COMPARATOR
Intervention: Honey Cocktail (20g/day)
Number of subjects: 100
Study 26836285 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffuse pain pattern
Number of subjects: 164
Study 26836285 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior-medial pain pattern
Number of subjects: 164
Study 26836285 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial-posterior pain pattern
Number of subjects: 164
Study 26836285 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall pain patterns
Number of subjects: 164
Study 26836285 — intervention group
Group type: EXPERIMENTAL
Intervention: WOMAC and ICOAP scores
Number of subjects: 164
Study 26836285 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathic-like symptoms
Number of subjects: 164
Study 24593664 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical petroleum jelly (2 g/kg, twice daily until 34 weeks of gestation)
Number of subjects: 74
Study 24593664 — intervention group
Group type: COMPARATOR
Intervention: No topical petroleum jelly treatment (Control)
Number of subjects: 74
Study 22523271 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 999
Study 22523271 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 999
Study 22523271 — intervention group
Group type: EXPERIMENTAL
Intervention: BI strain
Number of subjects: 999
Study 22523271 — intervention group
Group type: COMPARATOR
Intervention: Non-BI strains
Number of subjects: 999
Study 22523271 — intervention group
Group type: EXPERIMENTAL
Intervention: BI infection
Number of subjects: 999
Study 20226040 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant FSH (Gonal-F)
Number of subjects: 0
Study 20226040 — intervention group
Group type: COMPARATOR
Intervention: human menopausal gonadotropin (hMG; Menopur)
Number of subjects: 0
Study 17366280 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG neurofeedback (NF) training to increase peak alpha frequency (PAF)
Number of subjects: 0
Study 17366280 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 15629989 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside ultrasound of the bladder performed before catheterization
Number of subjects: 248
Study 15629989 — intervention group
Group type: COMPARATOR
Intervention: Observation phase (no ultrasound)
Number of subjects: 248
Study 12552349 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil treatment
Number of subjects: 30
Study 10475357 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg Pygeum africanum extract twice daily
Number of subjects: 209
Study 10475357 — intervention group
Group type: COMPARATOR
Intervention: 100 mg Pygeum africanum extract once daily
Number of subjects: 209
Study 8984863 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation applied to the median nerve
Number of subjects: 3
Study 8984863 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation applied to the ulnar nerve
Number of subjects: 3
Study 8984863 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 3
Study 1683182 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 97
Study 1683182 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 97
Study 31117088 — intervention group
Group type: EXPERIMENTAL
Intervention: Enarodustat 2 mg
Number of subjects: 0
Study 31117088 — intervention group
Group type: EXPERIMENTAL
Intervention: Enarodustat 4 mg
Number of subjects: 0
Study 31117088 — intervention group
Group type: EXPERIMENTAL
Intervention: Enarodustat 6 mg
Number of subjects: 0
Study 31117088 — intervention group
Group type: EXPERIMENTAL
Intervention: Enarodustat (any dose)
Number of subjects: 0
Study 31117088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28540514 — intervention group
Group type: EXPERIMENTAL
Intervention: Myringotomy and ventilation tube insertion
Number of subjects: 43
Study 28540514 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 43
Study 25012183 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Intensity Intermittent Exercise (HIIE)
Number of subjects: 48
Study 25012183 — intervention group
Group type: COMPARATOR
Intervention: Lower Intensity Intermittent Exercise (LIIE)
Number of subjects: 48
Study 25012183 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 48
Study 23617248 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate (SH) 0.15% 1 drop × 5 times/day for 90 days
Number of subjects: 40
Study 23617248 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (SH) 0.15% + amino acids mixture 1 drop × 5 times/day for 90 days
Number of subjects: 40
Study 20877394 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground hazelnuts
Number of subjects: 48
Study 20877394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliced hazelnuts
Number of subjects: 48
Study 20877394 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole hazelnuts
Number of subjects: 48
Study 19158801 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin (10 ml kg(‐1))
Number of subjects: 33
Study 19158801 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) (10 ml kg(‐1))
Number of subjects: 33
Study 17680182 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural ropivacaine at 6 mg x h(‐1) (group R‐6)
Number of subjects: 60
Study 17680182 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural ropivacaine at 18 mg x h(‐1) (group R‐18)
Number of subjects: 60
Study 17680182 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural ropivacaine at 12 mg x h(‐1)
Number of subjects: 60
Study 10711584 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of stress and depressive symptoms in women who quit early in pregnancy.
Number of subjects: 819
Study 10711584 — intervention group
Group type: COMPARATOR
Intervention: Adjusting for level of addiction and other demographic factors.
Number of subjects: 819
Study 10711584 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of stress and depressive symptoms.
Number of subjects: 819
Study 10711584 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted intensive cessation interventions.
Number of subjects: 819
Study 10711584 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions that reduce stress and depression.
Number of subjects: 819
Study 8968181 — intervention group
Group type: EXPERIMENTAL
Intervention: Pall BB2215 heat and moisture exchanger (HME) hydrophobic filter
Number of subjects: 23
Study 8968181 — intervention group
Group type: COMPARATOR
Intervention: Fisher Paykell hot water system
Number of subjects: 23
Study 8968181 — intervention group
Group type: COMPARATOR
Intervention: Dar Hygrobac 35254111 HME hygroscopic filter
Number of subjects: 23
Study 1637767 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayre's spatula
Number of subjects: 856
Study 1637767 — intervention group
Group type: COMPARATOR
Intervention: Aylesbury
Number of subjects: 856
Study 1637767 — intervention group
Group type: COMPARATOR
Intervention: Rocket
Number of subjects: 856
Study 1637767 — intervention group
Group type: COMPARATOR
Intervention: Multispatula
Number of subjects: 856
Study 1637767 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytobrush
Number of subjects: 856
Study 6143340 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0
Study 6143340 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0
Study 6143340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30651080 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional cash transfer (CCT) programme
Number of subjects: 554
Study 30651080 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 554
Study 29392749 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application-based treatment for urinary incontinence
Number of subjects: 0
Study 29392749 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study 26358951 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: two sessions of real MC rTMS
Number of subjects: 24
Study 26358951 — intervention group
Group type: COMPARATOR
Intervention: Group B: one session of real rTMS and one session of sham rTMS
Number of subjects: 24
Study 24374602 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative positioning device
Number of subjects: 100
Study 24374602 — intervention group
Group type: COMPARATOR
Intervention: Traditional positioning methods
Number of subjects: 100
Study 22746019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% after spinal anesthesia (0.2%S group)
Number of subjects: 81
Study 22746019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% after epidural anesthesia (0.2%E group)
Number of subjects: 81
Study 22746019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1% after epidural anesthesia (0.1%E group)
Number of subjects: 81
Study 20443719 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol gel (1 mg)
Number of subjects: 150
Study 20443719 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol valerate (2 mg) with or without medroxyprogesterone acetate (5 mg)
Number of subjects: 150
Study 20443719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 17355218 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin/pemetrexed combination chemotherapy
Number of subjects: 0
Study 17355218 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard chemotherapy options
Number of subjects: 0
Study 17355218 — intervention group
Group type: EXPERIMENTAL
Intervention: Newest biologically targeted therapies
Number of subjects: 0
Study 16287371 — intervention group
Group type: EXPERIMENTAL
Intervention: Superslow resistance training (SST) using 50% of 1RM
Number of subjects: 16
Study 16287371 — intervention group
Group type: COMPARATOR
Intervention: Traditional resistance training (TRT) using 80% of 1RM
Number of subjects: 16
Study 12119821 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (XyliFresh 100%, Hershey Food Corporation, U.S.A.) chewed three times a day for three weeks
Number of subjects: 61
Study 12119821 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study 14528568 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency exercise training program
Number of subjects: 114
Study 14528568 — intervention group
Group type: COMPARATOR
Intervention: High-frequency exercise training program
Number of subjects: 114
Study 8527615 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg famotidine
Number of subjects: 309
Study 8527615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309
Study 2260727 — intervention group
Group type: EXPERIMENTAL
Intervention: Borage oil (4.5 ml/day for 4 weeks)
Number of subjects: 29
Study 2260727 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (4.5 ml/day for 4 weeks)
Number of subjects: 29
Study 2260727 — intervention group
Group type: COMPARATOR
Intervention: Control (safflower oil, 4.5 ml/day for 4 weeks)
Number of subjects: 29
Study 31654345 — intervention group
Group type: EXPERIMENTAL
Intervention: OAGB-BSGP (staplerless one-anastomosis gastric bypass with band-separated gastric pouch)
Number of subjects: 80
Study 31654345 — intervention group
Group type: COMPARATOR
Intervention: Standard OAGB (stapled one-anastomosis gastric bypass)
Number of subjects: 80
Study 27292093 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological treatments for psoriasis (specifics on dosage and duration not provided)
Number of subjects: 0
Study 24870567 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity inspiratory muscle training (IMT)
Number of subjects: 28
Study 24870567 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity inspiratory muscle training (IMT)
Number of subjects: 28
Study 23386553 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural therapy (CBT)
Number of subjects: 78
Study 23386553 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills training for symptom management (SM)
Number of subjects: 78
Study 23386553 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 78
Study 21663610 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitality Exercise Programme (VEP) combined with three visits to a Personal Vitality Coach (PVC)
Number of subjects: 730
Study 20039417 — intervention group
Group type: EXPERIMENTAL
Intervention: Terguride
Number of subjects: 99
Study 20039417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 17175404 — intervention group
Group type: EXPERIMENTAL
Intervention: Precontemplation stage of change
Number of subjects: 301
Study 17175404 — intervention group
Group type: EXPERIMENTAL
Intervention: Action stage of change
Number of subjects: 301
Study 17175404 — intervention group
Group type: EXPERIMENTAL
Intervention: Both stages of change
Number of subjects: 301
Study 17175404 — intervention group
Group type: COMPARATOR
Intervention: Previous alcohol use, age, and education
Number of subjects: 301
Study 17175404 — intervention group
Group type: COMPARATOR
Intervention: Temptation to drink alcohol
Number of subjects: 301
Study 15897799 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline plasma interleukin (IL)-6 and soluble tumor necrosis factor receptor (sTNFR) 1 concentrations
Number of subjects: 124
Study 15897799 — intervention group
Group type: EXPERIMENTAL
Intervention: APACHE II and MOD scores, age
Number of subjects: 124
Study 15897799 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline total protein C, IL-8, IL-10, TNF-alpha, and procalcitonin concentrations
Number of subjects: 124
Study 15897799 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in plasma cytokine concentrations from baseline over the initial 4 days
Number of subjects: 124
Study 15897799 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of selected baseline proinflammatory cytokine concentrations and APACHE II score
Number of subjects: 124
Study 12201833 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation regimens
Number of subjects: 141
Study 12201833 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 141
Study 12201833 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional rehabilitation
Number of subjects: 141
Study 9615816 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow excision of primary tumor with 1 cm-wide margins in 305 patients
Number of subjects: 612